Regulation of VASP by phosphorylation Consequences for cell migration

Cell Adhesion and Migration

Volumn 7, Issue 6, 2013, Pages 482-486

  Döppler, Heike ^a   Storz, Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytoskeleton; Filopodium; Leading edge; Migration; Phosphorylation; VASP

Indexed keywords

CYTOSKELETON; FILOPODIUM; LEADING EDGE; MIGRATION; PHOSPHORYLATION; VASP;

CELL ADHESION MOLECULES; CELL MOVEMENT; HUMANS; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84894540610     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Pula G, Krause M. Role of Ena/VASP proteins in homeostasis and disease. Handb Exp Pharmacol 2008:39-65.
2. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003; 19:541-64; PMID:14570581; http://dx.doi.org/10.1146/annurev.cellbio.19. 050103.103356 (Pubitemid 37487360)
3. Kwiatkowski AV, Gertler FB, Loureiro JJ. Function and regulation of Ena/VASP proteins. Trends Cell Biol 2003; 13:386-92; PMID:12837609; http://dx.doi.org/10.1016/S0962-8924(03)00130-2 (Pubitemid 36776716)
4. Krause M, Bear JE, Loureiro JJ, Gertler FB. The Ena/VASP enigma. J Cell Sci 2002; 115:47216; PMID:12432060; http://dx.doi.org/10.1242/jcs.00218
5. Reinhard M, Jarchau T, Walter U. Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 2001; 26:243-9; PMID:11295557; http://dx.doi.org/10.1016/S0968-0004(00)01785-0 (Pubitemid 32293554)
6. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, Svitkina TM, Borisy GG, Gertler FB. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004; 42:37-49; PMID:15066263; http://dx.doi.org/10.1016/S0896-6273(04)00108-4 (Pubitemid 38456966)
7. Reinhard M, Jouvenal K, Tripier D, Walter U. Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilatorstimulated phosphoprotein). Proc Natl Acad Sci U S A 1995; 92:7956-60; PMID:7644520; http://dx.doi.org/10.1073/pnas.92.17.7956
8. Bear JE, Gertler FB. Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 2009; 122:1947-53; PMID:19494122; http://dx.doi.org/10.1242/jcs.038125
9. Trichet L, Sykes C, Plastino J. Relaxing the actin cytoskeleton for adhesion and movement with Ena/VASP. J Cell Biol 2008; 181:19-25; PMID:18378777; http://dx.doi.org/10.1083/jcb.200710168 (Pubitemid 351519760)
10. Barzik M, Kotova TI, Higgs HN, Hazelwood L, Hanein D, Gertler FB, Schafer DA. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 2005; 280:28653-62; PMID:15939738; http://dx.doi.org/10.1074/jbc.M503957200 (Pubitemid 41105766)
11. Bachmann C, Fischer L, Walter U, Reinhard M. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J Biol Chem 1999; 274:23549-57; PMID:10438535; http://dx.doi.org/10.1074/jbc.274.33.23549
12. Skoble J, Auerbuch V, Goley ED, Welch MD, Portnoy DA. Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility. J Cell Biol 2001; 155:89-100; PMID:11581288; http://dx.doi.org/10.1083/jcb.200106061 (Pubitemid 34286210)
13. Galler AB, García Arguinzonis MI, Baumgartner W, Kuhn M, Smolenski A, Simm A, Reinhard M. VASPdependent regulation of actin cytoskeleton rigidity, cell adhesion, and detachment. Histochem Cell Biol 2006; 125:457-74; PMID:16267652; http://dx.doi.org/10.1007/s00418-005-0091-z (Pubitemid 43673510)
14. Kühnel K, Jarchau T, Wolf E, Schlichting I, Walter U, Wittinghofer A, Strelkov SV. The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat. Proc Natl Acad Sci U S A 2004; 101:17027-32; PMID:15569942; http://dx.doi.org/10.1073/pnas.0403069101 (Pubitemid 39627768)
15. Ball LJ, Kühne R, Hoffmann B, Häfner A, Schmieder P, Volkmer-Engert R, Hof M, Wahl M, SchneiderMergener J, Walter U, et al. Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J 2000; 19:4903-14; PMID:10990454; http://dx.doi.org/10.1093/emboj/19.18.4903
16. Lambrechts A, Kwiatkowski AV, Lanier LM, Bear JE, Vandekerckhove J, Ampe C, Gertler FB. cAMPdependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J Biol Chem 2000; 275:36143-51; PMID:10945997; http://dx.doi.org/10.1074/jbc.M006274200
17. Applewhite DA, Barzik M, Kojima S, Svitkina TM, Gertler FB, Borisy GG. Ena/VASP proteins have an anti-capping independent function in filopodia formation. Mol Biol Cell 2007; 18:2579-91; PMID:17475772; http://dx.doi.org/10. 1091/mbc.E06-11-0990 (Pubitemid 47025723)
18. Harbeck B, Hüttelmaier S, Schluter K, Jockusch BM, Illenberger S. Phosphorylation of the vasodilatorstimulated phosphoprotein regulates its interaction with actin. J Biol Chem 2000; 275:30817-25; PMID:10882740; http://dx.doi.org/10.1074/jbc. M005066200
19. Ferron F, Rebowski G, Lee SH, Dominguez R. Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J 2007; 26:4597-606; PMID:17914456; http://dx.doi.org/10.1038/sj.emboj. 7601874 (Pubitemid 350036631)
20. Benz PM, Blume C, Moebius J, Oschatz C, Schuh K, Sickmann A, Walter U, Feller SM, Renne T. Cytoskeleton assembly at endothelial cell-cell contacts is regulated by alphaII-spectrin-VASP complexes. J Cell Biol 2008; 180:205-19; PMID:18195108; http://dx.doi.org/10.1083/jcb.200709181
21. Benz PM, Blume C, Seifert S, Wilhelm S, Waschke J, Schuh K, Gertler F, Münzel T, Renne T. Differential VASP phosphorylation controls remodeling of the actin cytoskeleton. J Cell Sci 2009; 122:395465; PMID:19825941; http://dx.doi.org/10.1242/jcs.044537
22. Doppler HR, Bastea LI, Lewis-Tuffin LJ, Anastasiadis PZ, Storz P. Protein kinase D1-mediated phosphorylations regulate vasodilator-stimulated phosphoprotein (VASP) localization and cell migration. J Biol Chem 2013; 288:24382-93; PMID:23846685; http://dx.doi.org/10.1074/jbc.M113.474676
23. Wentworth JK, Pula G, Poole AW. Vasodilatorstimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem J 2006; 393:555-64; PMID:16197368; http://dx.doi.org/10.1042/BJ20050796 (Pubitemid 43099095)
24. Chitaley K, Chen L, Galler A, Walter U, Daum G, Clowes AW. Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett 2004; 556:211-5; PMID:14706852; http://dx.doi.org/10.1016/S0014-5793(03) 01435-2 (Pubitemid 38058581)
25. Storz P, Doppler H, Toker A. Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 2004; 24:2614-26; PMID:15024053; http://dx.doi.org/10. 1128/MCB.24.7.2614-2626.2004 (Pubitemid 38381256)
26. Cowell CF, Yan IK, Eiseler T, Leightner AC, Doppler H, Storz P. Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell Biochem 2009; 106:71428; PMID:19173301; http://dx.doi.org/10. 1002/jcb.22067
27. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. cAMPand cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 1994; 269:14509-17; PMID:8182057 (Pubitemid 24194005)
28. Zhuang S, Nguyen GT, Chen Y, Gudi T, Eigenthaler M, Jarchau T, Walter U, Boss GR, Pilz RB. Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation. J Biol Chem 2004; 279:10397-407; PMID:14679200; http://dx.doi.org/10.1074/jbc.M313048200 (Pubitemid 38372648)
29. Blume C, Benz PM, Walter U, Ha J, Kemp BE, Renne T. AMP-activated protein kinase impairs endothelial actin cytoskeleton assembly by phosphorylating vasodilator-stimulated phosphoprotein. J Biol Chem 2007; 282:4601-12; PMID:17082196; http://dx.doi.org/10.1074/jbc.M608866200 (Pubitemid 47100984)
30. Lara R, Mauri FA, Taylor H, Derua R, Shia A, Gray C, Nicols A, Shiner RJ, Schofield E, Bates PA, et al. An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene 2011; 30:351321; PMID:21423205; http://dx.doi.org/10.1038/onc.2011.61
31. Lee S, Chung CY. Role of VASP phosphorylation for the regulation of microglia chemotaxis via the regulation of focal adhesion formation/maturation. Mol Cell Neurosci 2009; 42:382-90; PMID:19733667; http://dx.doi.org/10.1016/j. mcn.2009.08.010
32. Routray C, Liu C, Yaqoob U, Billadeau DD, Bloch KD, Kaibuchi K, Shah VH, Kang N. Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am J Physiol Cell Physiol 2011; 301:C66-74; PMID:21451103; http://dx.doi.org/10.1152/ajpcell.00038.2011
33. Defawe OD, Kim S, Chen L, Huang D, Kenagy RD, Renne T, Walter U, Daum G, Clowes AW. VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. J Cell Physiol 2010; 222:2307; PMID:19798690; http://dx.doi.org/10.1002/jcp.21942
34. Zuzga DS, Pelta-Heller J, Li P, Bombonati A, Waldman SA, Pitari GM. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer. Int J Cancer 2012; 130:2539-48; PMID:21702043; http://dx.doi.org/10.1002/ijc.26257
35. Thomson DM, Ascione MP, Grange J, Nelson C, Hansen MD. Phosphorylation of VASP by AMPK alters actin binding and occurs at a novel site. Biochem Biophys Res Commun 2011; 414:2159; PMID:21945940; http://dx.doi.org/10.1016/j.bbrc.2011. 09.059
36. Machesky LM. Putting on the brakes: a negative regulatory function for Ena/VASP proteins in cell migration. Cell 2000; 101:685-8; PMID:10892738; http://dx.doi.org/10.1016/S0092-8674(00)80879-X
37. Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 2006; 27:31723; PMID:16678913; http://dx.doi.org/10.1016/j.tips.2006.04.003
38. Yuan J, Rey O, Rozengurt E. Activation of protein kinase D3 by signaling through Rac and the alpha subunits of the heterotrimeric G proteins G12 and G13. Cell Signal 2006; 18:1051-62; PMID:16198087; http://dx.doi.org/10.1016/j. cellsig.2005.08.017
39. Doppler H, Bastea LI, Eiseler T, Storz P. Neuregulin mediates F-actin-driven cell migration through inhibition of protein kinase D1 via Rac1 protein. J Biol Chem 2013; 288:455-65; PMID:23148218; http://dx.doi.org/10.1074/ jbc.M112.397448
40. Eiseler T, Schmid MA, Topbas F, Pfizenmaier K, Hausser A. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett 2007; 581:4279-87; PMID:17707375; http://dx.doi.org/10.1016/j.febslet.2007.07.079 (Pubitemid 47301866)
41. Eiseler T, Doppler H, Yan IK, Kitatani K, Mizuno K, Storz P. Protein kinase D1 regulates cofilinmediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 2009; 11:545-56; PMID:19329994; http://dx.doi.org/10.1038/ncb1861
42. Spratley SJ, Bastea LI, Doppler H, Mizuno K, Storz P. Protein kinase D regulates cofilin activity through p21-activated kinase 4. J Biol Chem 2011; 286:34254-61; PMID:21832093; http://dx.doi.org/10.1074/jbc.M111.259424
43. Janssens K, De Kimpe L, Balsamo M, Vandoninck S, Vandenheede JR, Gertler F, Van Lint J. Characterization of EVL-I as a protein kinase D substrate. Cell Signal 2009; 21:282-92; PMID:19000756; http://dx.doi.org/10.1016/j.cellsig.2008. 10.012
44. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H, Shishido T. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 2003; 278:21685-92; PMID:12672821; http://dx.doi.org/10.1074/jbc.M301447200 (Pubitemid 36792570)
45. Maruoka M, Sato M, Yuan Y, Ichiba M, Fujii R, Ogawa T, Ishida-Kitagawa N, Takeya T, Watanabe N. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion. Biochem J 2012; 441:889-99; PMID:22014333; http://dx.doi.org/10. 1042/BJ20110951
46. Michael M, Vehlow A, Navarro C, Krause M. c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis. Curr Biol 2010; 20:783-91; PMID:20417104; http://dx.doi.org/10. 1016/j.cub.2010.03.048
47. Storz P, Doppler H, Johannes FJ, Toker A. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J Biol Chem 2003; 278:17969-76; PMID:12637538; http://dx.doi.org/10.1074/jbc.M213224200 (Pubitemid 36799404)
48. Storz P, Toker A. Protein kinase D mediates a stressinduced NF-kappaB activation and survival pathway. EMBO J 2003; 22:109-20; PMID:12505989; http://dx.doi.org/10.1093/emboj/cdg009 (Pubitemid 36091274)
49. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004; 64:8585-94; PMID:15574765; http://dx.doi.org/10.1158/00085472.CAN-04-1136 (Pubitemid 39552071)
50. Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, Venturo I, Botti C, Jager E, Santoni A, et al. The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin Cancer Res 2006; 12:1470-8; PMID:16533770; http://dx.doi.org/10.1158/1078-0432.CCR-05-2027
51. Di Modugno F, Bronzi G, Scanlan MJ, Del Bello D, Cascioli S, Venturo I, Botti C, Nicotra MR, Mottolese M, Natali PG, et al. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int J Cancer 2004; 109:90918; PMID:15027125; http://dx.doi.org/10.1002/ijc.20094
52. Di Modugno F, Mottolese M, DeMonte L, Trono P, Balsamo M, Conidi A, Melucci E, Terrenato I, Belleudi F, Torrisi MR, et al. The cooperation between hMena overexpression and HER2 signalling in breast cancer. PLoS One 2010; 5:e15852; PMID:21209853; http://dx.doi.org/10.1371/journal.pone.0015852
53. Toyoda A, Kawana H, Azuhata K, Yu J, Omata A, Kishi H, Higashi M, Harigaya K. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Int J Oncol 2009; 34:5360; PMID:19082477
54. Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, Perracchio L, Carstens RP, Santoni A, Bissell MJ, Nisticó P. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proc Natl Acad Sci U S A 2012; 109:192805; PMID:23129656; http://dx.doi.org/10.1073/pnas.1214394109
55. Philippar U, Roussos ET, Oser M, Yamaguchi H, Kim HD, Giampieri S, Wang Y, Goswami S, Wyckoff JB, Lauffenburger DA, et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 2008; 15:81328; PMID:19081071; http://dx.doi.org/10.1016/j.devcel.2008.09.003
56. Mouneimne G, Hansen SD, Selfors LM, Petrak L, Hickey MM, Gallegos LL, Simpson KJ, Lim J, Gertler FB, Hartwig JH, et al. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 2012; 22:615-30; PMID:23153535; http://dx.doi.org/10.1016/j.ccr.2012.09.027
57. Dertsiz L, Ozbilim G, Kayisli Y, Gokhan GA, Demircan A, Kayisli UA. Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 2005; 60:576-81; PMID:15994266; http://dx.doi.org/10.1136/thx.2004.037622 (Pubitemid 40966212)
58. Liu K, Li L, Nisson PE, Gruber C, Jessee J, Cohen SN. Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol 1999; 19:3696-703; PMID:10207093 (Pubitemid 29193829)
59. Hasegawa Y, Murph M, Yu S, Tigyi G, Mills GB. Lysophosphatidic acid (LPA)-induced vasodilatorstimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells. Mol Oncol 2008; 2:54-69; PMID:19081821; http://dx.doi.org/10.1016/j.molonc.2008.03.009
60. Deguchi A, Soh JW, Li H, Pamukcu R, Thompson WJ, Weinstein IB. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G. Mol Cancer Ther 2002; 1:803-9; PMID:12492113